ALKERMES reported 150.38M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Amgen AMGN:US $ 1.33B 99M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Coherus Biosciences CHRS:US $ 51.28M 2.52M
Eli Lilly And LLY:US $ 1.63B 67.2M
Gilead Sciences GILD:US $ 1.36B 274M
Heron Therapeutics HRTX:US $ 32.12M 836K
Horizon Pharma HZNP:US 398.22M 25.49M
Intra Cellular Therapies ITCI:US $ 100.32M 24.86M
IONIS PHARMACEUT IONS:US $ 33.8M 325K
JAZZ PHA JAZZ:US 325.67M 16.86M
Johnson & Johnson JNJ:US $ 6.23B 288M
Marinus Pharmaceuticals MRNS:US 17.06M 5.32M
Merk MRK:US $ 2.42B 118M
Minerva Neurosciences NERV:US $ 2.83M 196.19K
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Otsuka Holdings 4578:JP 184.9B 30.4B
Pfizer PFE:US $ 3.2B 506M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Revance Therapeutics RVNC:US $ 46.19M 2.21M
Teva Pharmaceutical Industries TEVA:US 849M 30M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K